Wandercraft launches Eve, first FDA-cleared home exoskeleton

Paris-based Wandercraft commercially launched Eve on September 17, 2026, the first FDA-cleared self-balancing personal exoskeleton for home use by wheelchair users with spinal cord injuries. The Class II device (510(k) K260381) needs no crutches, is available at 180+ National Seating and Mobility locations and is billable under Medicare code K1007. Pricing was not disclosed.

• FDA granted 510(k) K260381 in August 2026 as a Class II device
• No crutches: physical AI keeps balance, leaving both hands free
• Available at 180+ National Seating and Mobility locations in the US
• Medicare billing via HCPCS code K1007; price undisclosed